These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 22174670)
21. Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81. Tian ZF; Shen H; Fu XH; Chen YC; Blum HE; Baumert TF; Zhao XP World J Gastroenterol; 2009 Jan; 15(2):240-4. PubMed ID: 19132776 [TBL] [Abstract][Full Text] [Related]
22. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding. Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180 [TBL] [Abstract][Full Text] [Related]
32. Analysis of a conserved RGE/RGD motif in HCV E2 in mediating entry. Rothwangl KB; Rong L Virol J; 2009 Jan; 6():12. PubMed ID: 19171049 [TBL] [Abstract][Full Text] [Related]
33. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo. Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007 [TBL] [Abstract][Full Text] [Related]
34. Diverse CD81 proteins support hepatitis C virus infection. Flint M; von Hahn T; Zhang J; Farquhar M; Jones CT; Balfe P; Rice CM; McKeating JA J Virol; 2006 Nov; 80(22):11331-42. PubMed ID: 16943299 [TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus entry and the tetraspanin CD81. Farquhar MJ; Harris HJ; McKeating JA Biochem Soc Trans; 2011 Apr; 39(2):532-6. PubMed ID: 21428934 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648 [TBL] [Abstract][Full Text] [Related]
37. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry. Drummer HE; Boo I; Maerz AL; Poumbourios P J Virol; 2006 Aug; 80(16):7844-53. PubMed ID: 16873241 [TBL] [Abstract][Full Text] [Related]
38. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. Owsianka A; Clayton RF; Loomis-Price LD; McKeating JA; Patel AH J Gen Virol; 2001 Aug; 82(Pt 8):1877-1883. PubMed ID: 11457993 [TBL] [Abstract][Full Text] [Related]
39. Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines. Wellnitz S; Klumpp B; Barth H; Ito S; Depla E; Dubuisson J; Blum HE; Baumert TF J Virol; 2002 Feb; 76(3):1181-93. PubMed ID: 11773394 [TBL] [Abstract][Full Text] [Related]
40. Identification of ligands that target the HCV-E2 binding site on CD81. Olaby RA; Azzazy HM; Harris R; Chromy B; Vielmetter J; Balhorn R J Comput Aided Mol Des; 2013 Apr; 27(4):337-46. PubMed ID: 23612915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]